- Home
- POAI vs SBFM Comparison
POAI vs SBFM Comparison
Compare POAI & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- SBFM
- Stock Information
- Founded
- POAI 2002
- SBFM 2006
- Country
- POAI United States
- SBFM United States
- Employees
- POAI N/A
- SBFM N/A
- Industry
- POAI Industrial Specialties
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- SBFM Health Care
- Exchange
- POAI Nasdaq
- SBFM Nasdaq
- Market Cap
- POAI 7.8M
- SBFM 6.7M
- IPO Year
- POAI N/A
- SBFM N/A
- Fundamental
- Price
- POAI $14.77
- SBFM $1.67
- Analyst Decision
- POAI Hold
- SBFM Strong Buy
- Analyst Count
- POAI 1
- SBFM 1
- Target Price
- POAI N/A
- SBFM $15.00
- AVG Volume (30 Days)
- POAI 230.9K
- SBFM 62.2K
- Earning Date
- POAI 11-11-2025
- SBFM 11-04-2025
- Dividend Yield
- POAI N/A
- SBFM N/A
- EPS Growth
- POAI N/A
- SBFM N/A
- EPS
- POAI N/A
- SBFM N/A
- Revenue
- POAI $1,664,696.00
- SBFM $36,341,741.00
- Revenue This Year
- POAI $486.27
- SBFM $32.20
- Revenue Next Year
- POAI $65.50
- SBFM $32.74
- P/E Ratio
- POAI N/A
- SBFM N/A
- Revenue Growth
- POAI 71.65
- SBFM 19.22
- 52 Week Low
- POAI $8.25
- SBFM $1.17
- 52 Week High
- POAI $45.90
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- POAI 78.34
- SBFM 67.82
- Support Level
- POAI $12.15
- SBFM $1.50
- Resistance Level
- POAI $15.15
- SBFM $1.67
- Average True Range (ATR)
- POAI 1.98
- SBFM 0.08
- MACD
- POAI 1.19
- SBFM 0.01
- Stochastic Oscillator
- POAI 45.66
- SBFM 73.44
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.